Organ transplantation and obesity: Evaluation, risks and benefits of therapeutic strategies

Obesity Surgery

Volumn 10, Issue 5, 2000, Pages 465-469

  Weiss, H ^a   Nehoda, H ^a   Labeck, B ^a   Oberwalder, M ^a   Aigner, F ^a   Konigsrainer, A ^a   Margreiter, R ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Adjustable gastric banding; Bariatric surgery; Morbid obesity; Organ transplantation

Indexed keywords

ADULT; ARTICLE; BARIATRIC SURGERY; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DISEASE COURSE; GASTRIC BANDING; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; MORBID OBESITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; COMORBIDITY; GASTROPLASTY; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; OBESITY, MORBID; POSTOPERATIVE PERIOD;

EID: 0033710798     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089200321593977     Document Type: Article

References (41)

1. Body-mass index and mortality in a prospective cohort of U.S. adults
2. Overweight and obesity in the mortality rate data: Current evidence and research issues
3. The effect of body mass index on long-term renal allograft survival
4. Is obesity still a risk factor in renal transplantation?
5. Obesity as a risk factor after combined pancreas/kidney transplantation
6. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation
7. Are preoperative obesity and cachexia risk factors for post-heart transplant morbidity and mortality: A multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group
8. Injection port complications after gastric banding: Incidence, management and prevention
9. The impact of pre-transplant obesity on renal transplant outcomes
10. Defining obesity in patients undergoing orthotopic heart transplantation: Body mass index versus percent body fat
11. Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays
12. Immune response in ovemutrition
13. Cell-mediated immunity in genetically obese C57BL/6J ob/ob) mice
14. Hypothalamic and genetic obesity in experimental animals: An autonomic and endocrine hypothesis
15. Drug distribution in obesity and following bariatric surgery: A literature review
16. Influence of obesity on drug disposition
17. Extrahepatic sulfation and glucuronidation in the rat in vivo. Determination of the hepatic extraction ratio of harmol and the extrahepatic contribution to harmol conjugation
18. Treatment of renal allograft acute rejection with methylprednisolone: Effect of fixed dose versus dose per body mass index
19. Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation
20. Patients with morbid obesity don't get life-saving bone marrow transplants
21. Plasma immunoreactive leptin and neuropeptide Y levels in kidney transplant patients
22. Leptin in CAPD patients: Serum concentrations and peritoneal loss
23. Plasma leptin concentration in kidney transplant patients during the early post-transplant period
24. Hyperleptinaemia of end-stage renal disease is corrected by renal transplantation
25. Pathophysiological role of leptin in patients with chronic renal failure, in kidney transplant patients, in patients with essential hypertension, and in pregnant women with preeclampsia
26. Leptin sensitive neurons in the hypothalamus
27. The importance of obesity and hyperlipidaemia in patients with renal transplants
28. Weight change and obesity after liver transplantation: Incidence and risk factors
29. Update: NIH consensus conference. Gastrointestinal surgery for severe obesity
30. Current concepts in the pharmacological management of obesity
31. Preparation of extremely obese patients for laparoscopic gastric banding by gastric-balloon therapy
32. An examination of the renal transplant evaluation process focusing on cost and the reasons for patient exclusion
33. The effect of dietary intervention on weight gains after renal transplantation
34. Effect of diet and fluvastatin treatment on the serum lipid profile of kidney transplant, diabetic recipients: A 1-year follow up
35. Age and changes in dietary habits affect hyperlipoproteinemia after kidney transplantation
36. Gastric bypass in morbidly obese kidney transplant recipients
37. Adverse effect of abdominal operations on production of interferon-gamma
38. Splenic microabscesses in the immune-compromised patient
39. Surgery in immunosuppressed patients with emergency or elective indications
40. Altered flow properties of blood and increased plasma fibrinogen in cyclosporin-treated renal allograft recipients
41. Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/Enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors